User profiles for T. Huizinga

TWJ Huizinga

Leiden University Medical Center
Verified email at lumc.nl
Cited by 111010

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

…, JE Gottenberg, JMW Hazes, T Huizinga… - Annals of the …, 2017 - ard.bmj.com
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international Task …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

…, D Aletaha, M Buch, L Gossec, T Huizinga… - Annals of the …, 2010 - ard.bmj.com
Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear
and consensual international recommendations on RA treatment are not available. In this …

Cytokine gene polymorphism in human disease: on-line databases

…, L Keen, G Gallagher, R Kimberly, T Huizinga… - Genes & …, 1999 - nature.com
The pathologies of many infectious, autoimmune and malignant diseases are influenced by
the profiles of cytokine production in pro-inflammatory (TH1) and anti-inflammatory (TH2) T

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

…, JMW Hazes, K Hobbs, TWJ Huizinga… - Arthritis & …, 2010 - Wiley Online Library
Objective The 1987 American College of Rheumatology (ACR; formerly, the American
Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized …

Genetics of rheumatoid arthritis contributes to biology and drug discovery

…, MAFJ Van De Laar, HJ Guchelaar, TWJ Huizinga… - Nature, 2014 - nature.com
… at lysine 4 (H3K4me3) peaks in primary CD4 + regulatory T cells (T reg cells; P < 1.0 × 10
−5 ). For the RA risk loci enriched with T reg H3K4me3 peaks, we incorporated the epigenetic …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

…, JE Gottenberg, ML Hetland, TWJ Huizinga… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

…, E Flynn, P Harrison, LJ Hocking, TWJ Huizinga… - Nature …, 2010 - nature.com
To identify new genetic risk factors for rheumatoid arthritis, we conducted a genome-wide
association study meta-analysis of 5,539 autoantibody-positive individuals with rheumatoid …

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical …

…, J Font, IM Gilboe, F Houssiau, T Huizinga… - Annals of the …, 2008 - ard.bmj.com
Objective: Systemic lupus erythematosus (SLE) is a complex disease with variable
presentations, course and prognosis. We sought to develop evidence-based recommendations …

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study

…, CL Verweij, REM Toes, TWJ Huizinga - Arthritis & …, 2004 - Wiley Online Library
Objective Rheumatoid arthritis (RA) is a common, severe, chronic inflammatory joint disease.
Since the disease may initially be indistinguishable from other forms of arthritis, early …

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing …

…, A Doria, JG Hanly, TWJ Huizinga… - Annals of the …, 2010 - ard.bmj.com
Objectives To develop recommendations for the diagnosis, prevention and treatment of
neuropsychiatric systemic lupus erythematosus (NPSLE) manifestations. Methods The authors …